Lucian Duta, president of the National Health Insurance House (CNAS), said Wednesday that morphine supplier Mundipharma is being restructured, but this would not affect deliveries of their products. According to Duta, CNAS received a letter from the company, which said Mundipharma has placed orders or is in the process of importing every registered product “in sufficient quantities to cover demand.”
A press release from CNAS says the National Oncology Program will receive the same funding as last year.
According to people close to the matter, Prime Minister Mihai Razvan Ungureanu has asked Health Minister Ladislau Ritli to evaluate the creation of a national emergency medicine reserve, and present the results next week.
There were more than 10,000 registered cancer patients in January.
Mundipharma recently announced that the restructuring is a consequence of tougher conditions on the Romanian pharmaceutical market, the considerable increase in exposure to financial risks and intolerable taxation.